Companies › VIR

VIR BIOTECHNOLOGY INC COM (VIR)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001706431 · EDGAR filings · Updated 2026-07-24

VIR BIOTECHNOLOGY INC COM (VIR) has reported institutional ownership of 82.7%, with 252 institutional managers holding positions valued at $1.25B per the latest 13F reporting period.

Filings this week (1)

• 2026-07-24 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-29 — Notice of proposed sale filed (Form 144)
• 2026-06-10 — Insider transaction reported (Form 4)
• 2026-06-10 — Initial insider ownership filed (Form 3)
• 2026-06-10 — Current report (8-K) filed
• 2026-06-02 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, VIR BIOTECHNOLOGY INC COM has 252 institutional holders and institutional ownership of 82.7%.

Insider activity

Insiders reported 74 transactions (0 buys, 54 sells) across 16 reporting insiders, with a net reported value of −$20.8M.

Related companies

AVEANNA HEALTHCARE HLDGS INC (AVAH) · BAUSCH HEALTH COS INC (BHC) · WAVE LIFE SCIENCES LTD (WVE) · COLLEGIUM PHARMACEUTICAL INC COM (COLL) · ALPHATEC HLDGS INCORPORATED COM NEW (ATEC) · TAYSHA GENE THERAPIES (TSHA)